...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Profile and Survival of Tongue Cancer Patients in “Dharmais” Cancer Hospital, Jakarta
【24h】

Profile and Survival of Tongue Cancer Patients in “Dharmais” Cancer Hospital, Jakarta

机译:雅加达“ Dharmais”癌症医院的舌癌患者的概况和生存

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Tongue cancer is still a major health problem in most developing countries around the world.Statistics shown the number of tongue cancers, especially in early age, to be increasing, with poor survival.Objective: To analyze the characteristic profile of tongue cancer patients in Indonesia as well as the survivalrate. Materials and Methods: A cross sectional study was conducted in Dharmais National Cancer Hospitalby collecting general, clinical, and survival data of tongue cancer patients from medical records for January2009 to April 2012. Results: Tongue cancer incidence increased year by year. The average age of tongue cancerpatients was 47.5 years, and males predominated, accounting for 64.5% of cases. Most patients presented at anadvanced stage (69.6%). The histopathology type was squamous cell carcinoma in the vast majoriy (96.8%).The therapies applied were surgery (45.6%), radiation (63.6%) and chemotherapy (57.6%). The survival rateafter one year is 60.6% and after two years was 12.1%. In addition, median survival of tongue cancer patientswas 20 months (95% confidence interval 9.07-30.9). The significant factor affecting survival was size of tumorwith a hazard ratio of 3.18 (95% CI, 1.02-9.93; p 0.046) for largest versus smallest categories. Conclusions: Ineach year, the number of tongue cancer incidents in Indonesia is increasing. The age of tongue cancer patientsin Indonesia is younger compared to other countries. Moreover, the survival rates are not high.
机译:背景:舌癌仍然是世界上大多数发展中国家的主要健康问题,统计数据表明舌癌的数量正在增加,尤其是在早期阶段,生存率很低。目的:分析舌癌患者的特征在印度尼西亚的生存率。资料和方法:在达美斯国家癌症医院进行了一项横断面研究,收集了2009年1月至2012年4月的舌癌患者的一般,临床和生存数据。结果:舌癌的发病率逐年增加。舌癌患者的平均年龄为47.5岁,其中男性占主导地位,占病例的64.5%。大多数患者处于晚期(69.6%)。组织病理学类型主要为鳞状细胞癌(96.8%),采用的疗法为手术(45.6%),放射线(63.6%)和化学疗法(57.6%)。一年后的存活率为60.6%,两年后为12.1%。此外,舌癌患者的中位生存期为20个月(95%置信区间9.07-30.9)。影响生存率的重要因素是肿瘤的大小,最大和最小分类的危险比为3.18(95%CI,1.02-9.93; p 0.046)。结论:在印尼,每年发生的舌癌事件都在增加。与其他国家相比,印度尼西亚的舌癌患者年龄更年轻。而且,成活率不高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号